Tacrolimus is an immunosuppressant medication that is primarily used to prevent organ rejection in patients who have undergone transplant surgery. The demand for tacrolimus has been on the rise in recent years due to several factors, including the increasing number of organ transplant surgeries, the rising prevalence of autoimmune diseases, and the availability of new formulations of the medication.
One of the major drivers of the rising demand for Tacrolimus Market is the increasing number of organ transplant surgeries being performed worldwide. According to data from the Global Observatory on Donation and Transplantation, there were approximately 139,000 organ transplant surgeries performed worldwide in 2019. Kidney transplants accounted for the majority of these surgeries, followed by liver, heart, lung, and pancreas transplants. As the number of transplant surgeries continues to increase, so too does the demand for tacrolimus.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/04/the-global-tacrolimus-market-is.html
Sign in to leave a comment.